Truscreen Group Ltd (NZSE:TRU) Share Price

Company Profile

Business description
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.
Contact
C/- HLB Mann Judd Limited
57 Symonds Street
Level 6, Equitable House
Grafton
Auckland1010
NZL
T: +64 93032243
https://www.truscreen.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2026
Employees
9

Recommended

Investors will get to see if the new strategy and capital management framework are working.

Brian Han | 27 January 2026

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 27 January 2026

Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.

Sarah Hansen | 26 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,250.60	50.70	-0.55%
CAC 40	8,152.82	21.67	0.27%
DAX 40	24,894.44	38.64	-0.15%
Dow JONES (US)	49,003.41	408.99	-0.83%
FTSE 100	10,207.80	58.95	0.58%
HKSE	27,790.60	663.65	2.45%
NASDAQ	23,817.10	215.74	0.91%
Nikkei 225	53,358.71	25.17	0.05%
NZX 50 Index	13,412.87	98.01	-0.73%
S&P 500	6,978.60	28.37	0.41%
S&P/ASX 200	8,933.90	40.40	-0.45%
SSE Composite Index	4,151.24	11.33	0.27%